Robot-Assisted Gait Training vs NMES in Parkinson's Disease (ROBO-NMES-PD)
Comparative Effects of Robot-Assisted Gait Training and Quadriceps Neuromuscular Electrical Stimulation Added to Standard Exercise Rehabilitation on Balance, Gait, Disease Severity, and Quadriceps Muscle Adaptations in Patients With Parkinson Disease: A Prospective Randomized Assessor-Blinded Clinical Trial
This prospective, randomized, assessor-blinded clinical trial aims to compare the effects of robot-assisted gait training and quadriceps neuromuscular electrical stimulation (NMES) when added to a standard exercise rehabilitation program in patients with Parkinson disease.
Participants will be randomly assigned to two parallel groups. Both groups will receive a standard rehabilitation program, while one group will additionally undergo robot-assisted gait training and the other group will receive quadriceps NMES. The interventions will be administered five days per week for six weeks.
Clinical outcomes, including balance, functional mobility, gait performance, and disease severity, will be evaluated at baseline, post-treatment, and follow-up (week 14). In addition, ultrasound-based assessments of quadriceps muscle thickness and cross-sectional area will be performed to investigate muscle adaptations.
The results of this study are expected to provide comparative evidence regarding the effectiveness of these two rehabilitation approaches and contribute to optimizing rehabilitation strategies in Parkinson disease.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This is a single-center, prospective, randomized, assessor-blinded clinical trial. The study will include patients with idiopathic Parkinson's disease who meet the eligibility criteria. After baseline assessment and written informed consent, participants will be randomly assigned to one of two parallel intervention groups.
All participants will receive a standard Parkinson rehabilitation program including posture exercises, balance and coordination training, stretching and relaxation exercises, functional gait training, and lower extremity strengthening exercises. In addition to this standard program, one group will receive robot-assisted gait training and the other group will receive neuromuscular electrical stimulation applied to the quadriceps muscle.
The intervention period will last six weeks, with treatment sessions performed five days per week. Participants will be evaluated at baseline, at the end of the six-week treatment period, and at follow-up in week 14. Clinical assessments will be performed by an assessor blinded to group allocation. Ultrasonographic measurements of the quadriceps muscle will also be performed using a standardized technique.
The study is designed to compare the clinical and muscle-related effects of these two adjunctive rehabilitation approaches in Parkinson's disease.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: dilek Ün Oğuzhanasiltürk, MD
- Número de teléfono: +90 5056367184
- Correo electrónico: dilekunoguzhan@gmail.com
Ubicaciones de estudio
-
-
Istanbul
-
Küçükçekmece, Istanbul, Turquía (Türkiye), 34303
- Reclutamiento
- Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey
-
Contacto:
- Dilek Ün Oğuzhanasiltürk, MD
- Número de teléfono: +905056367184
- Correo electrónico: dilekunoguzhan@gmail.com
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Diagnosis of Parkinson's disease according to established clinical criteria
- Age between 40 and 80 years
- Hoehn and Yahr stage II-III
- Ability to walk independently with or without assistive devices
- Stable medical treatment for at least 4 weeks prior to study enrollment
- Ability to understand and follow instructions
- Willingness to participate and provide written informed consent
Exclusion Criteria:
- Severe cognitive impairment or inability to follow instructions
- Hoehn and Yahr stage IV-V Parkinson's disease
- Severe musculoskeletal disorders affecting gait (e.g., advanced osteoarthritis, recent fracture)
- History of lower extremity surgery within the last 6 months
- Severe cardiovascular or respiratory disease limiting exercise participation
- Presence of other neurological disorders affecting mobility (e.g., stroke, multiple sclerosis)
- Contraindications to electrical stimulation (e.g., pacemaker, implanted electronic devices)
- Skin lesions or infections at electrode placement sites
- Participation in another structured rehabilitation program within the last 3 months
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Robot-Assisted Gait Training Group
Participants in this group will receive a standard rehabilitation program in addition to robot-assisted gait training.
The intervention will be applied five days per week for six weeks.
|
Robot-assisted gait training applied in addition to a standard rehabilitation program including posture exercises, balance and coordination training, relaxation, and functional gait training in patients with Parkinson's disease.
This intervention is designed to improve gait performance, balance, and functional mobility.
|
|
Comparador activo: Quadriceps NMES Group
Participants in this group will receive a standard rehabilitation program in addition to quadriceps neuromuscular electrical stimulation (NMES).
The intervention will be applied five days per week for six weeks.
|
Quadriceps neuromuscular electrical stimulation (NMES) applied to the quadriceps muscle in addition to a standard rehabilitation program including posture exercises, balance and coordination training, relaxation, and functional gait training in patients with Parkinson's disease.
This intervention specifically targets improvement of quadriceps muscle strength and neuromuscular activation.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Timed Up and Go Test (TUG)
Periodo de tiempo: Baseline, 6 weeks, and 14 weeks
|
Assessment of functional mobility and balance using the Timed Up and Go test in patients with Parkinson's disease.
Lower completion times indicate better functional mobility.
|
Baseline, 6 weeks, and 14 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Berg Balance Scale
Periodo de tiempo: Baseline, 6 weeks, and 14 weeks
|
Evaluation of balance performance using the Berg Balance Scale (0-56 points; higher scores indicate better balance performance) in patients with Parkinson's disease.
|
Baseline, 6 weeks, and 14 weeks
|
|
Quadriceps Muscle Thickness
Periodo de tiempo: Baseline, 6 weeks, and 14 weeks
|
Ultrasound-based assessment of quadriceps muscle thickness (mm) in patients with Parkinson disease.
|
Baseline, 6 weeks, and 14 weeks
|
|
Quadriceps Cross-Sectional Area
Periodo de tiempo: Baseline, 6 weeks, and 14 weeks
|
Ultrasound-based assessment of quadriceps cross-sectional area (cm²) in patients with Parkinson disease.
|
Baseline, 6 weeks, and 14 weeks
|
Colaboradores e Investigadores
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- KSS-TRH-PD-ROBO-NMES-2026
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Enfermedad de Parkinson (EP)
-
Bezmialem Vakif UniversityIstanbul University - CerrahpasaAún no reclutandoEnfermedad de Parkinson | ENFERMEDAD DE PARKINSON (Trastorno) | Enfermedad de Parkinson (PD), equilibrio postural
-
Shanghai Xinzhi BioMed Co., Ltd.Reclutamiento
-
Oxford Biodynamics Inc.Community Clinical Oncology Research Network, LLCReclutamientoCáncer | Inmunoterapia | PD-L1 | PD-1 | Terapia de puntos de control inmunológicoEstados Unidos
-
Nandakumar NarayananNational Institute of Neurological Disorders and Stroke (NINDS)Inscripción por invitaciónEnfermedad de Parkinson & amp; amp;#39; s (PD)Estados Unidos
-
Samsung Medical CenterDesconocido
-
Tianjin Medical UniversityTianjin Medical University General HospitalReclutamientoMutación del gen PD-L1 | Tomografía de emisión de positrones | Amplificación del gen PD-L1 | PD-L1-related DiseasePorcelana
-
Agenus Inc.TerminadoCánceres sólidos avanzados | Cánceres sólidos avanzados refractarios a las terapias PD-1 y PD-L1Estados Unidos
-
Merck Sharp & Dohme LLCActivo, no reclutandoCáncer de pulmón de células no pequeñas | Tumores sólidos | Muerte celular programada-1 (PD1, PD-1) | Ligando 1 de muerte celular programada 1 (PDL1, PD-L1) | Ligando 2 de muerte celular programada 1 (PDL2, PD-L2)Japón
-
G. d'Annunzio UniversityTerminadoEnfermedad de Parkinson (PD), equilibrio posturalItalia
-
Jiangsu vcare pharmaceutical technology co., LTDTerminadoSujetos sanos | PK/PDPorcelana
Ensayos clínicos sobre robot -assisted gait training
-
IRCCS San Raffaele RomaTerminadoCarrera | Trastornos de la marcha, neurológicosItalia